Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach: lab in action. Palette: bold color field. A close, slightly high three-quarter angle on a gloved hand in white nitrile sliding a clear 24-well cell-culture plate out of a tissue-culture hood. The plate's wells hold pale pink medium, and one row glows a faint electric green. Behind the hand is a seamless, saturated deep teal wall that fills the frame. A multichannel pipette rests in the foreground at the lower right, with its tips softly out of focus. Soft, even overhead light from a fluorescent panel puts crisp highlights on the plastic lids and a small reflection on the glove's knuckles. Shadows are neutral grey-teal, not navy. The shallow depth of field keeps the wells sharp. The mood is focused, precise and quietly cautious, like early-stage preclinical work.
Longevity

NAD+ Boost Cut Heart Cell Aging and Stiffness in Old Male Mice

Lyra Voss · · 3 min read

The Headline Finding

Cardiac aging may be driven in part by a quiet drop in a molecule you've probably heard of: NAD+. A new mouse study in Cardiovascular Research (Huang et al.) suggests that restoring it can clear senescent heart cells and improve how the aged heart relaxes between beats. But the benefit showed up only in male mice, and the compound that did the most for the key longevity enzyme wasn't the familiar supplement.

What Went Wrong in the Aging Male Heart

The researchers compared young and aged mice of both sexes. In aged males, cardiac NAD+ levels were lower. According to the paper, three things contributed:

  • Impaired biosynthesis, so less NAD+ was being made
  • Limited mitochondrial mobilization, so less was available where it was needed
  • Increased consumption, so more was being used up

With less NAD+, the activity of two longevity-associated enzymes, SIRT1 and SIRT6, was suppressed. Senescent cardiomyocytes, heart muscle cells that have stopped dividing and stopped behaving normally, accumulated. The hearts also showed diastolic dysfunction (impaired relaxation and filling), myocardial hypertrophy, and fibrosis.

That matters because, as the authors note, cardiomyocyte senescence is a hallmark of cardiac aging and is closely linked to diastolic dysfunction and heart failure in older adults.

The Compound Spotlight: NR vs. NRH

The team tested two NAD+ precursors:

  • Nicotinamide riboside (NR), a well-known supplement ingredient
  • Dihydronicotinamide riboside (NRH), a reduced form of NR that is much less familiar

In cultured cardiomyocytes, depleting NAD+ induced senescence. Supplementing with either NR or NRH reversed it.

In aged male mice, two months of NR or NRH treatment:

  • Suppressed senescence markers
  • Improved diastolic function
  • Reduced hypertrophy and fibrosis

Why NRH Stood Out

Both compounds activated SIRT1 and suppressed markers of cell cycle arrest. But NRH produced the more robust SIRT1 activation. According to the authors, that SIRT1 activity deacetylated SIRT6, which helped SIRT6 bind to histones and enhanced DNA damage repair.

The abstract's conclusion is that NAD+ replenishment, particularly with NRH, reverses senescence-associated cardiac dysfunction through coordinated SIRT1 and SIRT6 activation. The abstract doesn't say NRH produced larger functional gains than NR, only stronger SIRT1 activation, so that distinction is worth keeping.

The Twist: Females Didn't Respond

Aged female mice also developed diastolic dysfunction. But their cardiac NAD+ levels did not significantly decline, and they did not respond to NR or NRH.

The authors take this to mean that cardiac aging runs on different mechanisms in the two sexes. In females, low NAD+ doesn't seem to be the problem, so refilling the tank didn't fix anything. The team stresses that biological sex has to be considered when developing NAD+-based therapies.

Practical Takeaways (With Honest Caveats)

You asked for dose, timing, and who it's for. Here is what the paper supports and where it stops.

Dose: The abstract doesn't report doses, and mouse doses can't be converted into a human supplement dose from this information. Anyone quoting a "heart-protective NR dose" from this study is guessing.

Timing: The mouse treatment lasted two months, started in already-aged animals. That suggests the effect isn't instant and that the intervention worked after aging was established. It says nothing about the best time of day or how long a person should take anything.

Who it might eventually be relevant for: The finding points toward older males with diastolic dysfunction or signs of cardiac aging. That is a hypothesis for future trials, not a recommendation.

Who should skip the hype:

  • Anyone expecting proven human benefit. The abstract reports no human data.
  • Women hoping for the same effect. In this study, aged female mice didn't respond.
  • People with diagnosed heart disease who might be tempted to replace or delay medical care with supplements. Talk to a cardiologist first.
  • Anyone looking for NRH as a product. The paper doesn't establish its safety or availability for human use.

What We Still Don't Know

  • Whether NAD+ drops in aging human hearts the way it does in male mice
  • Whether NRH works in people, and at what dose
  • Why females keep their cardiac NAD+ and still develop diastolic dysfunction
  • Whether benefits last after treatment stops

The Bottom Line

This study makes a clear mechanistic case that low NAD+ drives cardiomyocyte senescence in aging male mouse hearts, and that restoring it with NR, and especially NRH, can improve diastolic function while reducing hypertrophy and fibrosis. The sex-specific result is a warning against assuming one longevity strategy fits everyone. For now, it's a promising lead for researchers rather than a supplement protocol.

Source: Huang et al., "NAD+ replenishment reduces cardiomyocyte senescence and improves diastolic function in the aged male heart," Cardiovascular Research. DOI: 10.1093/cvr/cvag265. PubMed: https://pubmed.ncbi.nlm.nih.gov/42958931/

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
LV

Written by

Lyra Voss

Lyra Voss writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 4, conceptual metaphor, in palette D, bold color field. A single old brass pocket watch, photographed from a slightly high three-quarter angle, sits on a saturated mustard-yellow seamless backdrop. The watch case is cracked open and its glass is gone. One half of the gear train is clean and polished. The other half is corroded, with a dull green-black patina. A few fine droplets of clear liquid sit on the corroded gears, and one tiny electric green (#00e676) glint of oxidation shows at the edge of the damage. Hard but slightly diffused studio strobe from the upper left casts a crisp, short shadow on the yellow. The macro lens gives a shallow depth of field, with the sharpest focus on the split between healthy and damaged gears. The mood is cautionary, precise and quietly unsettling. No text or numerals appear on the dial.
longevity

The Anti-Aging Compound Spermidine Has a Dark Side in Old T Cells

BY DR. SYNAPSE ·

Spermidine is widely promoted as an anti-aging polyamine, but a new mouse-derived cell study found it can sabotage a specific group of old immune cells. In senescence-like CD49d- CD8+ T cells, it cut mitochondrial respiration, depleted antioxidant reserves, and fragmented mitochondria, while neighboring CD49d+ cells were untouched. Cells from young mice responded differently, which makes age a key variable. This is preclinical work, not evidence of harm in humans, but it challenges the idea that spermidine helps every aging cell. Here's what the paper found and what it does and doesn't mean for you.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A single analog wall clock with a blank white face and plain black hands, photographed straight-on against a saturated mustard-yellow backdrop. Its glass is slightly fogged. Several translucent multivitamin tablets, in the speckled orange-tan of a real multivitamin, rest on the clock's lower rim and in front of its face. One tablet is half-dissolved and leaves a faint haze on the glass. The clock hands sit just short of each other, hinting that the time barely shifted. Behind the clock a thin ghost shadow of a second clock hand falls a few degrees off, suggesting a nudge that isn't conclusive. A hair-thin electric green (#00e676) second hand adds a small accent. Soft, diffused studio light from the upper left creates gentle shadows on the yellow. The camera is at eye level with a shallow depth of field. The mood is wry and skeptical, curious but unconvinced.
longevity

A Cheap Multivitamin Nudged DHA Up—But the Aging Clocks Stayed Put

BY DR. SYNAPSE ·

Two years of a daily Centrum Silver gave older adults small bumps in DHA and omega-3 fatty acids and slowed the usual rise in creatinine, according to a COSMOS randomized trial analysis. Metabolomic risk scores for 16 chronic diseases also dipped, and all seven aging clocks trended 0.5 to 1.05 years younger. The twist is that none of it survived multiple-testing correction. Here is what the data show, what they don't, and who might care.
Approach: conceptual metaphor, with a natural palette. A single walnut is cracked open on a rough wooden board, and its two halves sit slightly apart. The halves are shot in tight macro from a low three-quarter angle. The walnut's brain-like folds are the focus. Between the halves, a thin cluster of fine, dark brown tannin-stained fibers stretches like a bridge. Beside it sits a small pile of shell fragments with a few strands of green walnut husk. A small, sharp, electric green (#00e676) leaf catches the light at the edge of the frame. The background is a softly blurred window-lit kitchen garden in leafy greens and warm earth tones. Soft natural daylight comes from the left and gives gentle shadows and visible texture on the nut's ridges. The mood is calm, curious and quietly scientific, with a fresh morning feel and no blue cast.
longevity

Urolithin A: The Walnut Gut Byproduct Tied to a Thicker Brain

BY NOVA CHEN ·

Eat a walnut and your gut bacteria turn its ellagitannins into urolithins, compounds that may be tied to how well your brain ages. In a 2-year MRI sub-study of the WAHA trial, bigger rises in urolithin A, urolithin C, and urolithin C glucuronide were associated with preserved cortical thickness among walnut eaters, mostly in right-hemisphere regions. The pattern was stronger in people with metabotype B gut profiles. But this is an association inside a randomized trial, not proof of cause, and it says nothing direct about urolithin A supplements. Here's what the data show, who might care, and who should stay skeptical.
**Approach: Conceptual metaphor. Palette: D, bold color field.** A single clear glass pipette dropper hangs just above a small glass dish on a saturated mustard-yellow seamless backdrop. One golden-amber droplet of oil falls from its tip, caught mid-air, with a faint ripple already spreading across the otherwise flat surface below. The dish is half-filled with clear fluid, a quiet nod to cerebrospinal fluid. The camera sits low and slightly off-axis, at a shallow 35° angle, with a macro lens and a softly blurred background. Large diffused studio light from the upper left gives crisp highlights on the glass and a clean, soft shadow on the yellow floor. A thin electric green reflection runs along the glass rim. The mood is sober and skeptical: a hopeful intervention producing a measurable ripple but no dramatic change. Photorealistic, with no text.
longevity

2 g of DHA a Day Reached the Brain in APOE4 Carriers, but Memory Did Not Budge

BY DR. SYNAPSE ·

A two-year trial gave older adults 2 grams of DHA a day. It moved a key marker in the fluid around the brain, but it did not change brain volumes or cognitive test performance. The study, published in EBioMedicine by Yassine and colleagues, tested the idea in people carrying the APOE ε4 gene variant and in people without it. It is one of the clearer reality checks the omega-3 field has had.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文